236 related articles for article (PubMed ID: 27982503)
1. T Cells Promote Bronchial Epithelial Cell Secretion of Matrix Metalloproteinase-9 via a C-C Chemokine Receptor Type 2 Pathway: Implications for Chronic Lung Allograft Dysfunction.
Pain M; Royer PJ; Loy J; Girardeau A; Tissot A; Lacoste P; Roux A; Reynaud-Gaubert M; Kessler R; Mussot S; Dromer C; Brugière O; Mornex JF; Guillemain R; Dahan M; Knoop C; Botturi K; Pison C; Danger R; Brouard S; Magnan A;
Am J Transplant; 2017 Jun; 17(6):1502-1514. PubMed ID: 27982503
[TBL] [Abstract][Full Text] [Related]
2. BALF cytokines in different phenotypes of chronic lung allograft dysfunction in lung transplant patients.
Berastegui C; Gómez-Ollés S; Sánchez-Vidaurre S; Culebras M; Monforte V; López-Meseguer M; Bravo C; Ramon MA; Romero L; Sole J; Cruz MJ; Román A
Clin Transplant; 2017 Mar; 31(3):. PubMed ID: 28008659
[TBL] [Abstract][Full Text] [Related]
3. The Role of TGF-β in the Association Between Primary Graft Dysfunction and Bronchiolitis Obliterans Syndrome.
DerHovanessian A; Weigt SS; Palchevskiy V; Shino MY; Sayah DM; Gregson AL; Noble PW; Palmer SM; Fishbein MC; Kubak BM; Ardehali A; Ross DJ; Saggar R; Lynch JP; Elashoff RM; Belperio JA
Am J Transplant; 2016 Feb; 16(2):640-9. PubMed ID: 26461171
[TBL] [Abstract][Full Text] [Related]
4. Quantitative chest CT for subtyping chronic lung allograft dysfunction and its association with survival.
Horie M; Salazar P; Saito T; Binnie M; Brock K; Yasufuku K; Azad S; Keshavjee S; Martinu T; Paul N
Clin Transplant; 2018 May; 32(5):e13233. PubMed ID: 29637624
[TBL] [Abstract][Full Text] [Related]
5. Systems prediction of chronic lung allograft dysfunction: Results and perspectives from the Cohort of Lung Transplantation and Systems prediction of Chronic Lung Allograft Dysfunction cohorts.
Pison C; Tissot A; Bernasconi E; Royer PJ; Roux A; Koutsokera A; Coiffard B; Renaud-Picard B; Le Pavec J; Mordant P; Demant X; Villeneuve T; Mornex JF; Nemska S; Frossard N; Brugière O; Siroux V; Marsland BJ; Foureau A; Botturi K; Durand E; Pellet J; Danger R; Auffray C; Brouard S; Nicod L; Magnan A;
Front Med (Lausanne); 2023; 10():1126697. PubMed ID: 36968829
[TBL] [Abstract][Full Text] [Related]
6. Pulmonary epithelial markers in phenotypes of chronic lung allograft dysfunction.
Levy L; Moshkelgosha S; Huszti E; Hunter S; Renaud-Picard B; Berra G; Kawashima M; Fernandez-Castillo J; Fuchs E; Dianti M; Ghany R; Keshavjee S; Singer LG; Tikkanen J; Martinu T
J Heart Lung Transplant; 2023 Aug; 42(8):1152-1160. PubMed ID: 36963446
[TBL] [Abstract][Full Text] [Related]
7. Spectrum of chronic lung allograft pathology in a mouse minor-mismatched orthotopic lung transplant model.
Martinu T; Oishi H; Juvet SC; Cypel M; Liu M; Berry GJ; Hwang DM; Keshavjee S
Am J Transplant; 2019 Jan; 19(1):247-258. PubMed ID: 30378739
[TBL] [Abstract][Full Text] [Related]
8. The Lymphatic Phenotype of Lung Allografts in Patients With Bronchiolitis Obliterans Syndrome and Restrictive Allograft Syndrome.
Traxler D; Schweiger T; Schwarz S; Schuster MM; Jaksch P; Lang G; Birner P; Klepetko W; Ankersmit HJ; Hoetzenecker K
Transplantation; 2017 Feb; 101(2):310-315. PubMed ID: 27163544
[TBL] [Abstract][Full Text] [Related]
9. Potential novel biomarkers for chronic lung allograft dysfunction and azithromycin responsive allograft dysfunction.
Veraar C; Kliman J; Benazzo A; Oberndorfer F; Laggner M; Hacker P; Raunegger T; Janik S; Jaksch P; Klepetko W; Ankersmit HJ; Moser B
Sci Rep; 2021 Mar; 11(1):6799. PubMed ID: 33762606
[TBL] [Abstract][Full Text] [Related]
10. Detection of chronic lung allograft dysfunction using ventilation-weighted Fourier decomposition MRI.
Voskrebenzev A; Greer M; Gutberlet M; Schönfeld C; Renne J; Hinrichs J; Kaireit T; Welte T; Wacker F; Gottlieb J; Vogel-Claussen J
Am J Transplant; 2018 Aug; 18(8):2050-2060. PubMed ID: 29607606
[TBL] [Abstract][Full Text] [Related]
11. Mechanistic differences between phenotypes of chronic lung allograft dysfunction after lung transplantation.
Suwara MI; Vanaudenaerde BM; Verleden SE; Vos R; Green NJ; Ward C; Borthwick LA; Vandermeulen E; Lordan J; Van Raemdonck DE; Corris PA; Verleden GM; Fisher AJ
Transpl Int; 2014 Aug; 27(8):857-67. PubMed ID: 24750386
[TBL] [Abstract][Full Text] [Related]
12. Longitudinal lung function measurements in single lung transplant recipients with chronic lung allograft dysfunction.
Leuschner G; Lauseker M; Howanietz AS; Milger K; Veit T; Munker D; Schneider C; Weig T; Michel S; Barton J; Meiser B; Dinkel J; Neurohr C; Behr J; Kneidinger N
J Heart Lung Transplant; 2020 Nov; 39(11):1270-1278. PubMed ID: 32917480
[TBL] [Abstract][Full Text] [Related]
13. Humoral immunity in phenotypes of chronic lung allograft dysfunction: A broncho-alveolar lavage fluid analysis.
Vandermeulen E; Verleden SE; Bellon H; Ruttens D; Lammertyn E; Claes S; Vandooren J; Ugarte-Berzal E; Schols D; Emonds MP; Van Raemdonck DE; Opdenakker G; Verleden GM; Vos R; Vanaudenaerde BM
Transpl Immunol; 2016 Sep; 38():27-32. PubMed ID: 27561239
[TBL] [Abstract][Full Text] [Related]
14. Low-dose computed tomography volumetry for subtyping chronic lung allograft dysfunction.
Saito T; Horie M; Sato M; Nakajima D; Shoushtarizadeh H; Binnie M; Azad S; Hwang DM; Machuca TN; Waddell TK; Singer LG; Cypel M; Liu M; Paul NS; Keshavjee S
J Heart Lung Transplant; 2016 Jan; 35(1):59-66. PubMed ID: 26342441
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of T Cell Alloreactivity by Bronchial Epithelium Is Impaired in Lung Transplant Recipients, Through Pathways Involving TGF-β, IL-10 and HLA-G.
Dupin C; Lhuillier E; Létuvé S; Pretolani M; Thabut G; Mal H; Carosella E; Schilte C; Mordant P; Castier Y; Bunel V; Danel C; Rouas-Freiss N; Brugière O
Transplantation; 2017 Sep; 101(9):2192-2199. PubMed ID: 27820781
[TBL] [Abstract][Full Text] [Related]
16. Phenotyping Chronic Lung Allograft Dysfunction Using Body Plethysmography and Computed Tomography.
Suhling H; Dettmer S; Greer M; Fuehner T; Avsar M; Haverich A; Welte T; Gottlieb J
Am J Transplant; 2016 Nov; 16(11):3163-3170. PubMed ID: 27203799
[TBL] [Abstract][Full Text] [Related]
17. HLA Matching at the Eplet Level Protects Against Chronic Lung Allograft Dysfunction.
Walton DC; Hiho SJ; Cantwell LS; Diviney MB; Wright ST; Snell GI; Paraskeva MA; Westall GP
Am J Transplant; 2016 Sep; 16(9):2695-703. PubMed ID: 27002311
[TBL] [Abstract][Full Text] [Related]
18. Validation of a post-transplant chronic lung allograft dysfunction classification system.
Van Herck A; Verleden SE; Sacreas A; Heigl T; Vanaudenaerde BM; Dupont LJ; Yserbyt J; Verbeken EK; Neyrinck AP; Van Raemdonck D; Verleden GM; Vos R
J Heart Lung Transplant; 2019 Feb; 38(2):166-173. PubMed ID: 30391199
[TBL] [Abstract][Full Text] [Related]
19. Self-reactive antibodies associated with bronchiolitis obliterans syndrome subtype of chronic lung allograft dysfunction.
Kaza V; Zhu C; Terada LS; Wang L; Torres F; Bollineni S; Mohanka M; Banga A; Joerns J; Mohanakumar T; Li QZ
Hum Immunol; 2021 Jan; 82(1):25-35. PubMed ID: 33129576
[TBL] [Abstract][Full Text] [Related]
20. Type-1 immunity and endogenous immune regulators predominate in the airway transcriptome during chronic lung allograft dysfunction.
Iasella CJ; Hoji A; Popescu I; Wei J; Snyder ME; Zhang Y; Xu W; Iouchmanov V; Koshy R; Brown M; Fung M; Langelier C; Lendermon EA; Dugger D; Shah R; Lee J; Johnson B; Golden J; Leard LE; Ellen Kleinhenz M; Kilaru S; Hays SR; Singer JP; Sanchez PG; Morrell MR; Pilewski JM; Greenland JR; Chen K; McDyer JF
Am J Transplant; 2021 Jun; 21(6):2145-2160. PubMed ID: 33078555
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
